Recent Analysts’ Ratings Changes for Core Scientific (CORZ)

Core Scientific (NASDAQ: CORZ) recently received a number of ratings updates from brokerages and research firms:

  • 10/15/2026 – Core Scientific had its “sell (d-)” rating reaffirmed by Weiss Ratings.
  • 10/15/2026 – Core Scientific had its “buy” rating reaffirmed by Canaccord Genuity Group. They now have a $36.00 price target on the stock.
  • 10/15/2026 – Core Scientific had its “buy” rating reaffirmed by BTIG Research. They now have a $38.00 price target on the stock.
  • 10/14/2026 – Core Scientific had its “market outperform” rating reaffirmed by Citigroup.
  • 10/14/2026 – Core Scientific had its “market outperform” rating reaffirmed by UBS Group.
  • 10/14/2026 – Core Scientific had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $39.00 price target on the stock.
  • 9/23/2026 – Core Scientific is now covered by UBS Group. They set a “buy” rating and a $24.00 price target on the stock.
  • 9/23/2026 – Core Scientific is now covered by UBS Group. They set a “buy” rating and a $24.00 price target on the stock.
  • 9/21/2026 – Core Scientific is now covered by Rothschild & Co Redburn. They set a “neutral” rating and a $16.00 price target on the stock.
  • 9/21/2026 – Core Scientific is now covered by Rothschild & Co Redburn. They set a “neutral” rating and a $16.00 price target on the stock.
  • 9/17/2026 – Core Scientific is now covered by Wells Fargo & Company. They set an “overweight” rating and a $28.00 price target on the stock.
  • 9/17/2026 – Core Scientific is now covered by Wells Fargo & Company. They set an “overweight” rating and a $28.00 price target on the stock.

Insider Buying and Selling

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction that occurred on Monday, October 19th. The shares were sold at an average price of $13.87, for a total value of $138,700.00. Following the transaction, the insider owned 1,143,286 shares of the company’s stock, valued at approximately $15,857,376.82. The trade was a 0.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Elizabeth Crain purchased 6,000 shares of Core Scientific stock in a transaction dated Thursday, August 20th. The stock was bought at an average price of $18.33 per share, with a total value of $109,980.00. Following the acquisition, the director directly owned 71,348 shares of the company’s stock, valued at approximately $1,307,808.84. This trade represents a 9.18% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders acquired 19,000 shares of company stock valued at $342,290 and sold 100,000 shares valued at $1,797,000. 1.70% of the stock is owned by company insiders.

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.

Read More

Receive News & Ratings for Core Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.